CYCCP
Cyclacel Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Sing Ee Wong
IPO Date
2005-11-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Cyclacel Pharmaceuticals, Inc.
CEO
Sing Ee Wong
IPO Date
2005-11-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 6,070 |
| $3.19 |
| 26 Dec 2023 | McBarron Paul | director, officer: See Remarks | P-Purchase | Acquired | 1,886 | $3.31 |
| 26 Dec 2023 | McBarron Paul | director, officer: See Remarks | P-Purchase | Acquired | 1,886 | $3.19 |
| 3 Jul 2023 | Rombotis Spiro George | director, officer: President and CEO | A-Award | Acquired | 110,000 | $0.59 |
| 3 Jul 2023 | McBarron Paul | director, officer: See Remarks | A-Award | Acquired | 70,200 | $0.59 |
| 3 Jul 2023 | Walker Karin L | director | A-Award | Acquired | 42,438 | $0.59 |
| 3 Jul 2023 | Walker Karin L | director | A-Award | Acquired | 21,219 | $0.00 |
| 3 Jul 2023 | Kirschbaum Mark | Chief Medical Officer | A-Award | Acquired | 70,200 | $0.59 |
| 3 Jul 2023 | SCHWARTZ BRIAN | director | A-Award | Acquired | 42,438 | $0.59 |